Gene therapy shows promise for treating Niemann-Pick disease type C1
Por um escritor misterioso
Descrição
NIH researchers demonstrated that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1.
Gene therapy shows promise for treating Niemann-Pick disease type C1
Potential treatment for Niemann-Pick type C, a rare neurodegenerative disease
Promising gene replacement therapy moves forward
Liposomal formulations for treating lysosomal storage disorders - ScienceDirect
Models to study basic and applied aspects of lysosomal storage disorders - ScienceDirect
Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics
Diseases, Free Full-Text
Miglustat improves swallowing in children and adolescents with Niemann-Pick type C1 disease
Frontiers Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases
Full article: Current advancements in therapy for Niemann-Pick disease: progress and pitfalls
Clinical applications of gene therapy for rare diseases: A review - Papaioannou - 2023 - International Journal of Experimental Pathology - Wiley Online Library
delta – Columbus Children's Foundation
de
por adulto (o preço varia de acordo com o tamanho do grupo)